Skip to main content
. 2016 Jun 16;4:60. doi: 10.1186/s40478-016-0331-6

Fig. 1.

Fig. 1

ATRX immunohistochemistry: a loss of immunoreactivity in necrotic/perinecrotic tumor areas, b Ambiguous ATRX status; areas with clear ATRX retention bordering areas with nuclear ATRX loss. c Diffuse astrocytoma grade II with ATRX loss, d Anaplastic Astrocytoma grade III with ATRX loss, e Oligodendroglioma grade II with ATRX retention, f Anaplastic Ependymoma with ATRX retention (f magnification ×200, a, ce magnification ×100, b magnification ×40)